PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 29 filers reported holding PHARMACYTE BIOTECH INC in Q1 2023. The put-call ratio across all filers is 8.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,930 | -27.2% | 23,300 | -0.9% | 0.00% | -100.0% |
| Q2 2023 | $67,210 | -3.8% | 23,500 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $69,840 | -5.4% | 24,000 | -4.8% | 0.00% | 0.0% |
| Q4 2022 | $73,836 | +23.1% | 25,200 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $60,000 | +1.7% | 24,800 | -5.3% | 0.00% | 0.0% |
| Q2 2022 | $59,000 | -1.7% | 26,200 | -0.4% | 0.00% | 0.0% |
| Q1 2022 | $60,000 | -21.1% | 26,300 | -13.5% | 0.00% | 0.0% |
| Q4 2021 | $76,000 | -72.9% | 30,400 | -65.5% | 0.00% | -66.7% |
| Q3 2021 | $280,000 | – | 88,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|